Cartesian Therapeutics, Inc. Logo

Cartesian Therapeutics, Inc.

A clinical-stage company developing mRNA-engineered cell therapies for autoimmune diseases.

RNAC | US

Overview

Corporate Details

ISIN(s):
US8162121045
LEI:
Country:
United States of America
Address:
7495 NEW HORIZON WAY, 21703 FREDERICK

Description

Cartesian Therapeutics, Inc. is a clinical-stage company that pioneers the development of mRNA-engineered cell therapies. The company's primary focus is on creating treatments for autoimmune diseases. Leveraging its novel mRNA technology platform, Cartesian develops therapeutic cells designed to target the drivers of these conditions. This approach aims to expand the reach and potential of cell therapy for patients with various autoimmune disorders. The company's lead asset, Descartes-08, is a central component of its clinical pipeline.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-06 22:19
FORM 4
English ZIP 7.3 KB
2026-01-06 22:19
FORM 4
English ZIP 7.5 KB
2026-01-06 22:19
FORM 4
English ZIP 7.3 KB
2026-01-06 22:19
FORM 4
English ZIP 7.5 KB
2026-01-06 22:18
FORM 4
English ZIP 7.5 KB
2026-01-06 22:18
FORM 4
English ZIP 7.4 KB
2026-01-06 22:18
FORM 4
English ZIP 7.5 KB
2026-01-06 22:18
FORM 4
English ZIP 7.3 KB
2026-01-06 22:18
FORM 4
English ZIP 7.5 KB
2026-01-06 22:18
FORM 4
English ZIP 8.0 KB
2026-01-06 22:18
FORM 4
English ZIP 7.6 KB
2026-01-06 22:18
FORM 4
English ZIP 7.5 KB
2026-01-02 22:03
FORM 4
English ZIP 7.6 KB
2025-12-18 23:05
FORM 4
English ZIP 7.3 KB
2025-12-18 23:03
FORM 3
English ZIP 609.7 KB

Automate Your Workflow. Get a real-time feed of all Cartesian Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cartesian Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cartesian Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.